# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 20190
- **Admission ID**: 157270
- **Row ID**: 2065
- **Profile Type**: FULL

## Demographics

- **Age**: 53
- **Sex**: F
- **Date of Birth**: 2085-01-05
- **Ethnicity**: WHITE
- **Marital Status**: SINGLE
- **Religion**: OTHER
- **Insurance**: Private
- **Admission Type**: ELECTIVE
- **Admission Date**: 2138-06-11 11:00:00
- **Discharge Date**: 2138-07-11 14:23:00

## Symptoms

- **mild peripheral edema** | severity: mild
- **tenderness and erythema near percutaneous endoscopic gastrostomy tube site (nearly resolved)**
- **fevers** | onset: on [**7-6**]
- **elevated white blood cell count** | onset: on [**7-6**]
- **cellulitis around percutaneous endoscopic gastrostomy tube site** | onset: on [**7-6**] | duration: nearly resolved at discharge

## Medical History

Hodgkin's lymphoma, status post radiation therapy in 2110 complicated by fibrothorax and restrictive pericarditis. Status post splenectomy for a staging laparotomy. Status post total abdominal hysterectomy/bilateral salpingo-oophorectomy. Restrictive lung disease requiring home oxygen.

## Allergies

INTRAVENOUS DYE

## Current Medications

- **Lasix** | dosage: 60 mg | frequency: p.o. q.d.
- **Iron** | dosage: 325 mg | frequency: p.o. q.d.
- **Epogen** | dosage: 40,000 units | frequency: subcutaneous every Thursday (to be discontinued after two more weeks)
- **Lopressor** | dosage: 12.5 mg | frequency: p.o. b.i.d.
- **Sertraline HCL** | dosage: 50 mg | frequency: p.o. q.d.
- **Levothyroxine** | dosage: 100 mcg | frequency: p.o. q.d.
- **Enoxaparin** | dosage: 30 mg | frequency: subcutaneous b.i.d.
- **Nystatin oral suspension** | dosage: 5 mL | frequency: p.o. q.i.d.
- **Lansoprazole oral solution** | dosage: 30 mg | frequency: p.o. q.d.
- **Albuterol nebulizers** | dosage: 5 puffs to 10 puffs | frequency: q.4h. and p.r.n.
- **Clindamycin** | dosage: 300 mg | frequency: p.o. q.6h. (to be discontinued on [**7-18**])
- **Calcium gluconate** | frequency: p.r.n.
- **Artifical Tears** | frequency: p.r.n.
- **Percocet elixir** | dosage: 5 mL to 10 mL | frequency: q.4-6h. p.r.n. via the percutaneous endoscopic gastrostomy tube
- **clindamycin** | frequency: oral, 2-week course | purpose: treatment of cellulitis
- **Respalor tube feeds** | dosage: 45 cc per hour | frequency: continuous | purpose: nutritional support

## Discharge Medications

- **clindamycin** | frequency: oral, 2-week course

## Diagnoses

- fibrothorax secondary to radiation therapy
- restrictive airway disease
- restrictive pericarditis (status post pericardectomy)
- Hodgkin's lymphoma, status post radiation therapy
- Status post left decortication
- Status post tracheostomy
- Status post percutaneous endoscopic gastrostomy tube
- **Methicillin-resistant Staphylococcus aureus and Enterobacter pneumonia** | notes: postoperative complication
- **Cellulitis around percutaneous endoscopic gastrostomy tube site** | notes: nearly resolved at discharge

## Treatment Options

### home oxygen

**Details**: for restrictive lung disease

### pericardectomy

**Details**: for restrictive pericarditis

### splenectomy

**Details**: for staging laparotomy

### total abdominal hysterectomy/bilateral salpingo-oophorectomy


### left decortication

**Details**: performed in operating room on [**2138-6-11**]

### tracheostomy

**Details**: performed on [**6-20**]

### bronchoscopy

**Details**: performed on [**7-4**]

### percutaneous endoscopic gastrostomy tube placement

**Details**: performed on [**7-4**]

### drain placement beside gastrostomy tube site

**Details**: for cellulitis and pus removal

### antibiotic therapy

**Details**: full course of vancomycin and ceftazidime for pneumonia; 2-week course of p.o. clindamycin for cellulitis begun on [**7-6**]

**Medications**:
- vancomycin (not provided)
- ceftazidime (not provided)
- clindamycin (not provided)

### tube feeding

**Details**: 45 cc per hour of full-strength Respalor tube feeds through gastrostomy tube
**Treatment**: nutritional support

### physical therapy

**Details**: vigorous, able to walk across ICU unassisted at discharge
